Trillium Therapeutics Inc. EBITDA Margin 2014-2021 | TRIL
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Trillium Therapeutics Inc. (TRIL) over the last 10 years. The current EBITDA margin for Trillium Therapeutics Inc. as of September 30, 2021 is .
| EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2020-06-30 | $0.00B | $-0.06B | inf% |
